These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 2044308)

  • 1. [Successful treatment of levodopa-induced neuroleptic malignant syndrome (NMS) with disseminated intravascular coagulation (DIC) in a patient with Parkinson's disease].
    Yamawaki Y; Ogawa N
    Rinsho Shinkeigaku; 1991 Jan; 31(1):62-7. PubMed ID: 2044308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A successfully treated parkinsonian patient with neuroleptic malignant syndrome complicated by status epilepticus and disseminated intravascular coagulation].
    Osoegawa M; Motomura S; Yamanaka H; Tamura K; Miyoshi T
    Rinsho Shinkeigaku; 1999 Jun; 39(6):653-7. PubMed ID: 10502992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of levodopa-induced neuroleptic malignant syndrome (NMS) and disseminated intravascular coagulation (DIC) in a patient with Parkinson's disease.
    Yamawaki Y; Ogawa N
    Intern Med; 1992 Nov; 31(11):1298-302. PubMed ID: 1295627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Malignant syndrome associated with disseminated intravascular coagulation and a high level of amylase in serum, followed by diabetic coma in an elderly patient with Parkinson's disease during L-dopa therapy].
    Saeki H; Muneta S; Kobayashi T
    Nihon Ronen Igakkai Zasshi; 1998 Feb; 35(2):139-44. PubMed ID: 9584493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A patient with Parkinson's disease complicated by hypothyroidism who developed malignant syndrome after discontinuation of etizolam].
    Kawajiri M; Ohyagi Y; Furuya H; Araki T; Inoue N; Esaki S; Yamada T; Kira J
    Rinsho Shinkeigaku; 2002 Feb; 42(2):136-9. PubMed ID: 12424963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemostatic evaluation of a patient with haloperidol-induced neuroleptic malignant syndrome associated with disseminated intravascular coagulation].
    Seki Y; Takahashi H; Aizawa Y
    Rinsho Ketsueki; 1998 May; 39(5):374-8. PubMed ID: 9637888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroleptic malignant syndrome in a patient with Parkinson's disease: a case study.
    Ward C
    J Neurosci Nurs; 2005 Jun; 37(3):160-2. PubMed ID: 16001822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A 74-year-old woman with parkinsonism and dementia who died four years after the onset].
    Okuma Y; Hattori N; Nobukawa B; Mori H; Suda K; Takubo H; Mizuno Y
    No To Shinkei; 1998 Jul; 50(7):671-82. PubMed ID: 9739528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Case of neuroleptic malignant syndrome following open heart surgery for thoracic aortic aneurysm with parkinson's disease].
    Shinoda M; Sakamoto M; Shindo Y; Ando Y; Tateda T
    Masui; 2013 Dec; 62(12):1453-6. PubMed ID: 24498782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A study of neuroleptic malignant syndrome in the presenium and senium].
    Suzuki I; Honma H; Watanabe N; Matsubara S; Koyama T
    Seishin Shinkeigaku Zasshi; 1998; 100(6):387-97. PubMed ID: 9745353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum cytokine level and production of reactive oxygen species (ROS) by blood neutrophils from a schizophrenic patient with hypersensitivity to neuroleptics.
    Kamińska T; Szuster-Ciesielska A; Wysocka A; Marmurowska-Michałowska H; Dubas-Slemp H; Kandefer-Szerszeń M
    Med Sci Monit; 2003 Jul; 9(7):CS71-5. PubMed ID: 12883457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A 85-year-old woman with the onset of progressive gait disturbance at 80 years of the age].
    Yoritaka A; Hattori T; Hattori Y; Mori H; Matsuoka S; Shirai T; Kondo T; Mizuno Y
    No To Shinkei; 1997 Apr; 49(4):379-89. PubMed ID: 9125748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroleptic malignant syndrome complicating levodopa withdrawal.
    Reutens DC; Harrison WB; Goldswain PR
    Med J Aust; 1991 Jul; 155(1):53-4. PubMed ID: 2067442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and treatment of neuroleptic malignant syndrome.
    Guerrero RM; Shifrar KA
    Clin Pharm; 1988 Sep; 7(9):697-701. PubMed ID: 3240662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy of neuroleptic malignant syndrome.
    Lazarus A
    Psychiatr Dev; 1986; 4(1):19-30. PubMed ID: 3703852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroleptic malignant syndrome with delayed onset of fever following risperidone administration.
    Norris B; Angeles V; Eisenstein R; Seale JP
    Ann Pharmacother; 2006 Dec; 40(12):2260-4. PubMed ID: 17119106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of a complicated case of neuroleptic malignant syndrome.
    Lappa A; Podestà M; Capelli O; Castagna A; Di Placido G; Alampi D; Semeraro F
    Intensive Care Med; 2002 Jul; 28(7):976-7. PubMed ID: 12122539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A-56-year-old woman with parkinsonism, whose mother had Parkinson's disease].
    Shimo Y; Takanashi M; Ohta S; Terashima K; Mori H; Shirai T; Miwa H; Mizuno Y
    No To Shinkei; 2001 May; 53(5):495-505. PubMed ID: 11428377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neuroleptic malignant syndrome].
    Murak E
    Psychiatr Pol; 1995; 29(3):349-58. PubMed ID: 7652088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neuroleptic malignant syndrome--a review.
    Gibb WR; Lees AJ
    Q J Med; 1985 Aug; 56(220):421-9. PubMed ID: 2864716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.